ARMOUR Pfd C ARRC Profitability Outlook Regeneron Pharmaceuticals REGN Posts Positive Phase 3 Cemdisiran gMG Trial Data But Valuation Headwinds Persist Xcel Energy Inc XEL Polar Power POLA shares tick higher despite quarterly loss investors seek revenue growth visibility AbbVie Inc ABBV Top Buy Candidate Amid Recent Pullback and Pipeline Catalyst Updates